CANNABIS THERAPEUTIC RESEARCH 
PROGRAM 
REPORT to the CALIFORNIA
LEGISLATURE 
Prepared by the 
RESEARCH ADVISORY PANEL 
350 McAllister Street, Room 6000 
San Francisco, California 94102 
TABLE OF CONTENTS
  - Panel Members and Staff 
- Executive Summary 
- Cancer Chemotherapy, Nausea and Vomiting 
      - The-Problem 
- Inadequacy of Drugs in Current Use 
- Early Experience with Marijuana and THC 
 
- Cannabis Therapeutic Program 
      - Legislative History 
- The Research Advisory Panel 
- Panel's Role in Development of Legislation 
- Summary of Legislation 
- Extension of Law and Provision for Glaucoma Studies 
 
- Implementation of the New Law 
      - Protocol Development 
- Drug Supply 
- Cost 
- Investigator Eligibility 
- Physician Enrollment 
- Research Subjects 
- Research Subject Protection 
 
- Study Objectives 
      - Protocol History 
- Data Collection 
- Data Quality Control 
- Abuse 
- Site Visits 
- Dissemination of Findings and Results 
 
- Detailed Protocol Results 
      - Number of Patients Treated 
- Initial Trial 
- Cumulative Dose Study 
- Combination Protocol 
- Results of Study with Smoked Marijuana 
- Protocol Exceptions (Pilot Protocols) 
- Results of the Controlled Study Protocols 
- Glaucoma Protocol 
- Post Marketing Survey of Investigators 
- Discussion of Results of Cannabis Therapeutic Program 
 
- Approval by FDA for Marketing of THC and Conclusion of the Cannabis Therapeutic Program 
      - Approval and Rescheduling 
- Investigational THC no Longer Supplied by NCI 
 
- Credits 
Contents | Feedback
| Search | DRCNet Home Page | Join DRCNet
DRCNet Library | Schaffer Library | Hemp (Marijuana) | Medical Information
 
      
      
      
Drug Rehab